These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Commissioning of a specialist service for Stevens-Johnson syndrome/toxic epidermal necrolysis: current management in England could be improved. George C; Creamer D; Moss C; Walsh S Br J Dermatol; 2016 Oct; 175(4):829. PubMed ID: 27106856 [No Abstract] [Full Text] [Related]
24. Rare diseases are a 'common' problem for clinicians. Elliott E; Zurynski Y Aust Fam Physician; 2015 Sep; 44(9):630-3. PubMed ID: 26488039 [TBL] [Abstract][Full Text] [Related]
25. Cancer care in the Czech Republic. Vorlícková H Eur J Oncol Nurs; 2004 Mar; 8(1):78-82. PubMed ID: 15003747 [No Abstract] [Full Text] [Related]
26. "People with rare cancers get a raw deal in research and care". Newlands J Nurs Times; 2012 Feb 7-13; 108(6):11. PubMed ID: 22720483 [No Abstract] [Full Text] [Related]
27. Setting up and running a familial cancer clinic. Ponder BA Br Med Bull; 1994 Jul; 50(3):732-45. PubMed ID: 7987652 [TBL] [Abstract][Full Text] [Related]
28. [Care for patients with rare diseases]. Smetsers SE; Takkenberg JJ; Bierings MB Ned Tijdschr Geneeskd; 2014; 158():A7960. PubMed ID: 25336312 [TBL] [Abstract][Full Text] [Related]
29. The evolving role of patient advocates in rare cancers: opportunities and challenges. Gonzato O; Gronchi A Expert Rev Pharmacoecon Outcomes Res; 2019 Feb; 19(1):1-3. PubMed ID: 30227750 [No Abstract] [Full Text] [Related]
30. Confronting a crisis in cancer care delivery. Bylander J Health Aff (Millwood); 2013 Oct; 32(10):1695-7. PubMed ID: 24101057 [TBL] [Abstract][Full Text] [Related]
31. The Care Continuum: An Evolving Model for Care and Research in Rare Diseases. Augustine EF; Dorsey ER; Saltonstall PL Pediatrics; 2017 Sep; 140(3):. PubMed ID: 28818836 [No Abstract] [Full Text] [Related]
32. [Challenges of interdisciplinary collaboration in the management of rare diseases]. Koczula G; Budych K; Helms TM; Schultz C Gesundheitswesen; 2012 Dec; 74(12):822-8. PubMed ID: 22275060 [TBL] [Abstract][Full Text] [Related]
33. Lesser-spotted zebras: Their care and feeding. Dickinson JA Can Fam Physician; 2016 Aug; 62(8):620-1. PubMed ID: 27521381 [No Abstract] [Full Text] [Related]
34. International rare cancers initiative. Keat N; Law K; Seymour M; Welch J; Trimble T; Lascombe D; Negrouk A Lancet Oncol; 2013 Feb; 14(2):109-10. PubMed ID: 23369681 [No Abstract] [Full Text] [Related]
36. Should clinical trials be approached differently for rare cancers? Olver I Future Oncol; 2016 May; 12(10):1207-9. PubMed ID: 26939845 [No Abstract] [Full Text] [Related]
37. Developing a strategy for the management of rare diseases. Taylor CM; Karet Frankl FE BMJ; 2012 Apr; 344():e2417. PubMed ID: 22498954 [No Abstract] [Full Text] [Related]
38. [Is "associativism" good for one's health? The case of rare diseases]. Barbosa RL; Portugal S Cien Saude Colet; 2018 Feb; 23(2):417-430. PubMed ID: 29412400 [TBL] [Abstract][Full Text] [Related]
39. Do we need randomised trials for rare cancers? Prasad V; Oseran A Eur J Cancer; 2015 Jul; 51(11):1355-7. PubMed ID: 25963018 [No Abstract] [Full Text] [Related]
40. [Public partners voices-why do communities support this dynamic?]. Med Sci (Paris); 2014 Apr; 30 Spe(1):61-2. PubMed ID: 24755182 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]